Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06125964 · ClinicalTrials.gov registry record · NA

eMOTION Formative Study

A NA study of Cancer and Physical Inactivity, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT06125964 is a NA study of Cancer and Physical Inactivity that has completed, run by University of Southern California. The registered enrollment target is 47 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06125964, a NA study of Cancer and Physical Inactivity, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

The eMOTION Study is a two-part ORBIT model phase 1 trial. The first part, called the Formative Study, will assess acceptability and feasibility of a novel physical activity intervention in adults at increased risk for cancer due to overweight or obesity.

Interventions

  • BEHAVIORAL Intensity-Based Goals
  • BEHAVIORAL Affect-Based Goals
  • BEHAVIORAL TYPE/CONTEXT Enhancement
  • BEHAVIORAL SAVOR Enhancement

Study Locations (1)

California

  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2023-10-06
Est. Completion 2024-06-30
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT06125964

The ClinicalTrials.gov registry entry for NCT06125964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Intensity-Based Goals is the first listed.

NCT06125964 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06125964 about?

NCT06125964 is a clinical study titled "eMOTION Formative Study". The eMOTION Study is a two-part ORBIT model phase 1 trial. The first part, called the Formative Study, will assess acceptability and feasibility of a novel physical activity intervention in adults at increased risk for cancer due to overweight or obesity.

What is the current status of trial NCT06125964?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2023-10-06. Estimated completion is 2024-06-30.

What conditions does trial NCT06125964 study?

This clinical trial studies the following conditions: Cancer, Physical Inactivity, Overweight or Obesity.

What interventions are being tested in trial NCT06125964?

The interventions under investigation include: Intensity-Based Goals (BEHAVIORAL), Affect-Based Goals (BEHAVIORAL), TYPE/CONTEXT Enhancement (BEHAVIORAL), SAVOR Enhancement (BEHAVIORAL).

Who is sponsoring clinical trial NCT06125964?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06125964 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.